相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs
Kashif Rafiq Zahid et al.
CARDIOVASCULAR RESEARCH (2020)
Clinical characteristics of pulmonary hypertension patients living in plain and high-altitude regions
Si Lei et al.
CLINICAL RESPIRATORY JOURNAL (2019)
Early Evidence for the Role of lncRNA TUG1 in Vascular Remodelling in Pulmonary Hypertension
Sebastien Bonnet et al.
CANADIAN JOURNAL OF CARDIOLOGY (2019)
Long non-coding RNAs influence the transcriptome in pulmonary arterial hypertension: the role of PAXIP1-AS1
Katharina Jandl et al.
JOURNAL OF PATHOLOGY (2019)
Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression
Haiyang Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase
Sunil Tomar et al.
CANCER LETTERS (2018)
Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression
Dan Li et al.
ONCOGENE (2018)
WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
Yu Pan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy
Min Wu et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Novel strategies for treatment of pulmonary arterial hypertension
Magdalena Jasińska-Stroschein et al.
Postepy Higieny I Medycyny Doswiadczalnej (2017)
Effects of fasudil on pulmonary hypertension in clinical practice
Yiqing Zhang et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2017)
Immune cells and autoantibodies in pulmonary arterial hypertension
Cheng Li et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2017)
RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro
Yun Xia et al.
ANTI-CANCER DRUGS (2017)
WIP promotes in-vitro invasion ability, anchorage independent growth and EMT progression of A549 lung adenocarcinoma cells by regulating RhoA levels
Amrita Salvi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Pulmonary arterial hypertension: Basic knowledge for clinicians
Diana Santos-Ribeiro et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2016)
miR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression
Yanwei Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
PDGF-dependent -catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension
Jack Takahashi et al.
FEBS LETTERS (2016)
ROCK2 mediates the proliferation of pulmonary arterial endothelial cells induced by hypoxia in the development of pulmonary arterial hypertension
Feng Qiao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
A global view of pulmonary hypertension
Marius M. Hoeper et al.
LANCET RESPIRATORY MEDICINE (2016)
Novel ROCK inhibitors for the treatment of pulmonary arterial hypertension
Duncan Shaw et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Overexpression of RhoA promotes the proliferation and migration of cervical cancer cells
Xiaojun Liu et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2014)
Targeting RhoA/ROCK pathway in pulmonary arterial hypertension
Sabina Antonela Antoniu
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Heparin Inhibits Pulmonary Artery Smooth Muscle Cell Proliferation through Guanine Nucleotide Exchange Factor-H1/RhoA/Rho Kinase/p27
Lunyin Yu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Preventive effects of fasudil on adriamycin-induced cardiomyopathy: Possible involvement of inhibition of RhoA/ROCK pathway
Na Wang et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension
Hiroshi Fujita et al.
HEART AND VESSELS (2010)
The Transcription Factor ETS-1 Mediates Proinflammatory Responses and Neointima Formation in Carotid Artery Endoluminal Vascular Injury
Wenguang Feng et al.
HYPERTENSION (2010)
Atorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells
SJ Wu et al.
RESPIRATORY RESEARCH (2005)
分享论文
